市場調査レポート

商品コード

1403336

毒性試験の世界市場予測（～2030年）：製品、試験タイプ、方法、技術、エンドユーザー、地域別の分析

Toxicology Testing Market Forecasts to 2030 - Global Analysis By Product, Test Type, Method, Technology, End User and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 597,849円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 756,315円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 914,781円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,080,450円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の毒性試験の市場規模は、予測期間中に15.9%のCAGRで成長しています。

毒性試験は、人間の健康や環境に対する潜在的な危険性を評価するために、物質が生物に及ぼす影響を評価することを含みます。化学物質、医薬品、消費者製品、環境汚染物質に関連する安全性、毒性、リスクを判断します。その重要性は、リスクの特定と軽減、規制遵守の支援、製品開発の指針によって公衆衛生を守ることにあります。

NCBIによると、探索段階で合成された1万化合物に対して、前臨床段階に到達するのはわずか250化合物であり、最終的にFDAに承認される医薬品は1つです。

研究開発活動の増加

製薬、バイオテクノロジー、化学製造などの業界では、新規化合物、製剤、製品の探索が絶え間なく行われています。毒性試験は、これらの革新的技術の安全性、有効性、潜在的リスクを市場導入前に評価することにより、これらのセグメントで極めて重要な役割を果たしています。さらに、しっかりとした毒性評価は、規制基準への準拠を保証し、人の健康や環境への悪影響を軽減するのに役立ちます。消費者の要求の変化や技術の飛躍的進歩に対応するための研究開発努力が高まるにつれ、徹底した毒性試験の必要性は高まっており、新規の医薬品、化学物質、製品の創出と承認に不可欠なステップとなっています。

データ解釈の複雑さ

多くの実験や最先端技術から生み出される複雑で多様なデータは、分析に困難をもたらし、有用な洞察への変換を困難にしています。この複雑さを正確に評価するには、特定の知識、高度な機器、標準化されたフレームワークが必要です。このような複雑な統計データを解釈する際の誤りや不確実性は、リスク評価、規制当局への申請、製品開発における意思決定を損ない、市場の承認や開発を妨げる可能性があります。

代替試験法に対する需要の高まり

試験管内アッセイ、オルガノイド、マイクロ流体システム、計算モデルなどの先端技術は、毒性評価に有望な代替手段を提供し、より正確で費用対効果が高く、倫理的な試験手段を提供します。これらの代替法を検証し、商業化するための研究開発に投資している企業は、このような需要の高まりに資本投下する立場にあります。さらに、これらの代替法が広く採用されることで、試験プロセスが合理化され、より迅速な結果が得られるようになり、より人道的で予測可能な毒性評価を求める世界の動向とも一致します。このように、市場拡大の原動力となっています。

規制の変化

安全性評価を管理する規制の進化と厳格化は、試験手法、バリデーション要件、製品承認のタイムラインに影響を与えるため、継続的な適応と遵守を必要とします。規制基準の突然のシフトや新しいガイドラインの導入は、不確実性、コスト増、承認プロセスの遅延につながる可能性があります。新基準に迅速に対応できなかった場合、コンプライアンス違反の罰則、競争力の低下、市場参入の阻害につながる可能性があり、毒性試験市場において効率性を維持し、進化する要件に対応することが企業にとって課題となります。

COVID-19の影響

COVID-19の発生は、当初は操業停止と研究への影響により、リソースをパンデミック関連研究に振り向けることになりました。試験と規制プロセスの遅延が続き、製品の承認が遅れました。しかし、この危機はワクチン開発と医薬品安全性評価における毒性試験の重要性を浮き彫りにし、その重要性を高めました。業界はリモートワークとバーチャル試験で対応し、イノベーションとデジタル化を促進しました。安全性評価に対する認識が高まった結果、堅牢な調査手法が改めて重視されるようになり、パンデミック後の回復への道が開かれました。

予測期間中、遺伝子毒性試験セグメントが最大となる見込み

遺伝子毒性試験セグメントが最大のシェアを占めると推定されます。遺伝子毒性試験は、物質の突然変異、染色体異常、DNA損傷を誘発する能力を評価するアッセイを採用しており、潜在的な発がん物質や有害化合物を特定する上で極めて重要です。これらの試験には、エームス試験、小核試験、コメット試験などの体外・生体内の方法が含まれ、遺伝毒性を総合的に分析します。さらに、遺伝子毒性を理解することは、医薬品、化学物質、農薬、消費者製品の安全性を判断するのに役立ち、規制評価に大きく貢献し、有害な遺伝子変化から人の健康と環境を確実に保護します。

予測期間中にCAGRが最も高くなると予想されるのは、生体内試験セグメントです。

予測期間中、生体内試験セグメントは有利な成長を遂げると予測されています。生体内試験とは、植物や動物などの生きた生物全体で実施される実験の一種です。毒性レベル、有害反応、潜在的な健康被害を判定するのに役立ち、規制評価や安全性評価に重要なデータを提供します。さらに、倫理的な配慮にもかかわらず、これらの試験は、物質の生物学的影響を包括的に理解し、潜在的に有害な化合物から人の健康と環境を確実に保護するために不可欠です。

最大のシェアを占める地域

アジア太平洋は、工業化の進展、規制ガイドラインの厳格化、環境安全性に関する意識の高まりにより、予測期間中最大の市場シェアを占めました。技術の進歩、製薬・バイオテクノロジーセグメントの拡大、化粧品や食品産業における毒性評価への需要が、市場拡大の原動力となっています。さらに、中国、インド、日本、韓国のような国々は、経済の拡大と研究イニシアチブの拡大により、極めて重要な貢献をしています。この市場の成長を後押ししているのは、製品の安全性評価が重視され、信頼性の高い毒性試験法が必要とされていることです。

CAGRが最も高い地域：

北米は、厳しい規制の枠組み、製品の安全性への関心の高まり、技術の進歩により、予測期間中に収益性の高い成長を遂げると予想されます。同地域は製薬・バイオテクノロジー産業が確立しており、研究開発活動も活発化していることから、市場の拡大が見込まれています。さらに、化学物質への曝露に対する懸念の高まりと、医療、化粧品、環境モニタリングなど様々なセグメントにおける効率的な毒性評価の必要性が、市場の成長を促進しています。米国やカナダなどの主要貢献国は、試験手法の継続的な進歩を示しており、技術革新と市場浸透を促進しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第12章企業プロファイル

Abbott Laboratories
Eurofins Scientific
Laboratory Corporation Of America Holdings
Thermo Fisher Scientific, Inc.
Danaher Corporation
Agilent Technolgies, Inc.
Catalent, Inc.
Bio-Rad Laboratories, Inc.
Bioivt
Gentronix

図表

List of Tables

Table 1 Global Toxicology Testing Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 4 Global Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 5 Global Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 6 Global Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 7 Global Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 8 Global Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 9 Global Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 10 Global Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 11 Global Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 12 Global Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 13 Global Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 14 Global Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 15 Global Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 16 Global Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 17 Global Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 18 Global Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 19 Global Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 20 Global Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 21 Global Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 22 Global Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 23 Global Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 24 North America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
Table 25 North America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 26 North America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 27 North America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 28 North America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 29 North America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 30 North America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 31 North America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 32 North America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 33 North America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 34 North America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 35 North America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 36 North America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 37 North America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 38 North America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 39 North America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 40 North America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 41 North America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 42 North America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 43 North America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 44 North America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 45 North America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 46 North America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 47 Europe Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
Table 48 Europe Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 49 Europe Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 50 Europe Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 51 Europe Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 52 Europe Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 53 Europe Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 54 Europe Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 55 Europe Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 56 Europe Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 57 Europe Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 58 Europe Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 59 Europe Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 60 Europe Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 61 Europe Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 62 Europe Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 63 Europe Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 64 Europe Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 65 Europe Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 66 Europe Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 67 Europe Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 68 Europe Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 69 Europe Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 70 Asia Pacific Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
Table 71 Asia Pacific Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 72 Asia Pacific Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 73 Asia Pacific Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 74 Asia Pacific Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 75 Asia Pacific Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 76 Asia Pacific Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 77 Asia Pacific Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 78 Asia Pacific Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 79 Asia Pacific Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 80 Asia Pacific Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 81 Asia Pacific Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 82 Asia Pacific Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 83 Asia Pacific Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 84 Asia Pacific Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 85 Asia Pacific Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 86 Asia Pacific Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 87 Asia Pacific Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 88 Asia Pacific Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 89 Asia Pacific Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 90 Asia Pacific Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 91 Asia Pacific Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 92 Asia Pacific Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 93 South America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
Table 94 South America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 95 South America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 96 South America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 97 South America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 98 South America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 99 South America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 100 South America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 101 South America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 102 South America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 103 South America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 104 South America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 105 South America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 106 South America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 107 South America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 108 South America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 109 South America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 110 South America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 111 South America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 112 South America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 113 South America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 114 South America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 115 South America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Table 116 Middle East & Africa Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
Table 117 Middle East & Africa Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
Table 118 Middle East & Africa Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
Table 119 Middle East & Africa Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
Table 120 Middle East & Africa Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
Table 121 Middle East & Africa Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
Table 122 Middle East & Africa Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
Table 123 Middle East & Africa Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
Table 124 Middle East & Africa Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
Table 125 Middle East & Africa Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
Table 126 Middle East & Africa Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
Table 127 Middle East & Africa Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
Table 128 Middle East & Africa Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
Table 129 Middle East & Africa Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
Table 130 Middle East & Africa Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
Table 131 Middle East & Africa Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
Table 132 Middle East & Africa Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
Table 133 Middle East & Africa Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
Table 134 Middle East & Africa Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
Table 135 Middle East & Africa Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
Table 136 Middle East & Africa Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
Table 137 Middle East & Africa Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
Table 138 Middle East & Africa Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24561

According to Stratistics MRC, the Global Toxicology Testing Market is growing at a CAGR of 15.9% during the forecast period. Toxicology testing involves evaluating the effects of substances on living organisms to assess potential hazards to human health and the environment. It determines the safety, toxicity, and risks associated with chemicals, pharmaceuticals, consumer products, and environmental pollutants. Its importance lies in safeguarding public health by identifying and mitigating risks, aiding regulatory compliance, and guiding product development.

According to NCBI, for every 10,000 compounds synthesized in the discovery phase, only 250 reach the preclinical phase, ultimately resulting in one approved drug by the FDA.

Market Dynamics:

Driver:

Increasing R&D activities

Industries such as pharmaceuticals, biotechnology, and chemical manufacturing are continually exploring novel compounds, formulations, and products. Toxicology testing plays a pivotal role in these sectors by evaluating the safety, efficacy, and potential risks of these innovations before market introduction. Moreover, robust toxicological assessments ensure compliance with regulatory standards and help mitigate adverse effects on human health and the environment. The need for thorough toxicological testing is growing as R&D efforts to address changing consumer demands and technological breakthroughs rise, making it an essential step in the creation and approval of novel medications, chemicals, and products.

Restraint:

Complexity in data interpretation

The complex and varied data produced by many experiments and cutting-edge technologies presents analytical difficulties that make it difficult to analyze and translate into useful insights. Accurate assessment of this complexity necessitates specific knowledge, advanced instruments, and standardized frameworks. Errors or uncertainty when interpreting these complex statistics can impair decision-making in risk assessments, regulatory filings, and product development, thereby impeding market approvals and developments.

Opportunity:

Growing demand for alternative testing methods

Advanced technologies such as in vitro assays, organoids, microfluidics systems, and computational models offer promising alternatives for toxicology assessments, providing more accurate, cost-effective, and ethical testing avenues. Companies investing in research and development to validate and commercialize these alternative methods stand to capitalize on this growing demand. Moreover, the widespread adoption of these alternatives also streamlines testing processes, fosters quicker results, and aligns with the global trend towards more humane and predictive toxicology evaluations. Thus, there is propelling market expansion.

Threat:

Regulatory changes

Evolving and stringent regulations governing safety assessments necessitate continuous adaptation and compliance, impacting testing methodologies, validation requirements, and timelines for product approvals. Sudden shifts in regulatory standards or the introduction of new guidelines may lead to uncertainties, increased costs, and delays in the approval process. Failure to promptly align with new standards could result in non-compliance penalties, reduced competitiveness, and impediments to market access, posing challenges for companies in maintaining efficiency and meeting evolving requirements within the toxicology testing market.

COVID-19 Impact

The COVID-19 outbreak initially affected operations and research due to lockdowns and redirected resources towards pandemic-related studies. Delays in trials and regulatory processes ensued, slowing down product approvals. However, the crisis highlighted the criticality of toxicology testing in vaccine development and drug safety assessments, elevating its importance. The industry adapted with remote work and virtual trials, fostering innovation and digitalization. Increased awareness of safety evaluations resulted in a renewed emphasis on robust testing methodologies, paving the way for a resilient recovery post-pandemic.

The genetic toxicology testing segment is expected to be the largest during the forecast period

The genetic toxicology testing segment is estimated to hold the largest share. Genetic toxicology testing employs assays to evaluate a substance's ability to induce mutations, chromosomal aberrations, or DNA damage, which is crucial in identifying potential carcinogens or harmful compounds. These tests encompass in vitro and in vivo methods, such as the Ames test, micronucleus assay, and comet assay, to comprehensively analyze genotoxicity. Moreover, understanding genetic toxicity aids in determining the safety of pharmaceuticals, chemicals, pesticides, and consumer products, contributing significantly to regulatory evaluations, and ensuring the protection of human health and the environment from harmful genetic alterations.

The in-vivo testing segment is expected to have the highest CAGR during the forecast period

The in-vivo testing segment is anticipated to have lucrative growth during the forecast period. In vivo tests refer to a type of experiment that is carried out within a whole, living organism, such as a plant or animal. It helps to determine toxicity levels, adverse reactions, and potential health hazards, providing crucial data for regulatory assessments and safety evaluations. Moreover, these tests, despite ethical considerations, remain essential for comprehensively understanding the biological effects of substances and ensuring the protection of human health and the environment from potentially harmful compounds.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing industrialization, stringent regulatory guidelines, and rising awareness regarding environmental safety. Advancements in technology and expanding pharmaceutical and biotechnology sectors, coupled with the demand for toxicological evaluations in the cosmetics and food industries, drive market expansion. Moreover, countries like China, India, Japan, and South Korea are pivotal contributors due to their expanding economies and growing research initiatives. This market's growth is fuelled by the emphasis on product safety assessment and the need for reliable toxicology testing methods.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks, heightened focus on product safety, and technological advancements. The region's well-established pharmaceutical and biotechnology industries, along with increased R&D activities, propel market expansion. Moreover, rising concerns about chemical exposure, coupled with the need for efficient toxicological evaluations in various sectors, including healthcare, cosmetics, and environmental monitoring, are driving market growth. Key contributors like the United States and Canada witness continual advancements in testing methodologies, fostering innovation and market penetration.

Key players in the market:

Some of the key players in the Toxicology Testing Market include Abbott Laboratories, Eurofins Scientific, Laboratory Corporation Of America Holdings, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technolgies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., Bioivt and Gentronix.

Key Developments:

In November 2023, Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In September 2023, Thermo Fisher Scientific and National Minority Quality Forum Collaborate to support biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or health condition being studied, including U.S. Food and Drug Administration requirements around diversity action plans.

Products Covered:

Instruments
Reagents and Kits
Other Products

Test Types Covered:

Genetic Toxicology Testing
Carcinogenicity Testing
Developmental and Reproductive Toxicology Testing
Other Test Types

Methods Covered:

Biochemical Testing
Hematology Testing
Pathology Testing

Technologies Covered:

In-vivo Testing
In-vitro Testing

End Users Covered:

Food and Beverage Industry
Pharmaceutical and Biotechnology Companies
Cosmetics and Personal Care Industry
Academic and Research Institutions
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Toxicology Testing Market, By Product

5.1 Introduction
5.2 Instruments
5.3 Reagents and Kits
5.4 Other Products

6 Global Toxicology Testing Market, By Test Type

6.1 Introduction
6.2 Genetic Toxicology Testing
6.3 Carcinogenicity Testing
6.4 Developmental and Reproductive Toxicology Testing
6.5 Other Test Types

7 Global Toxicology Testing Market, By Method

7.1 Introduction
7.2 Biochemical Testing
7.3 Hematology Testing
7.4 Pathology Testing

8 Global Toxicology Testing Market, By Technology

8.1 Introduction
8.2 In-vivo Testing
8.3 In-vitro Testing

9 Global Toxicology Testing Market, By End User

9.1 Introduction
9.2 Food and Beverage Industry
9.3 Pharmaceutical and Biotechnology Companies
9.4 Cosmetics and Personal Care Industry
9.5 Academic and Research Institutions
9.6 Other End Users

10 Global Toxicology Testing Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Abbott Laboratories
12.2 Eurofins Scientific
12.3 Laboratory Corporation Of America Holdings
12.4 Thermo Fisher Scientific, Inc.
12.5 Danaher Corporation
12.6 Agilent Technolgies, Inc.
12.7 Catalent, Inc.
12.8 Bio-Rad Laboratories, Inc.
12.9 Bioivt
12.10 Gentronix

毒性試験の世界市場予測（～2030年）：製品、試験タイプ、方法、技術、エンドユーザー、地域別の分析

Toxicology Testing Market Forecasts to 2030 - Global Analysis By Product, Test Type, Method, Technology, End User and By Geography

COVID-19の影響

最大のシェアを占める地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の毒性試験市場：製品別

第6章 世界の毒性試験市場：試験タイプ別

第7章 世界の毒性試験市場：方法別

第8章 世界の毒性試験市場：技術別

第9章 世界の毒性試験市場：エンドユーザー別

第10章 世界の毒性試験市場：地域別

第11章 主な発展

第12章 企業プロファイル